Edward F. Mackey's most recent trade in Boston Scientific Corp. was a trade of 2,444 Deferred Stock Units done . Disclosure was reported to the exchange on Feb. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,444 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,444 | 54,028 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.17 per share. | 28 Feb 2022 | 1,084 | 52,944 (0%) | 0% | 44.2 | 47,880 | Common Stock |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 14,823 | 14,823 | - | - | Performance Share Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 2,726 | 2,726 | - | - | Deferred Stock Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 2,726 | 52,793 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 21 Feb 2022 | 1,209 | 51,584 (0%) | 0% | 42.6 | 51,443 | Common Stock |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 23,719 | 58,154 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 23,719 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 17 Feb 2022 | 10,310 | 50,067 (0%) | 0% | 42.6 | 438,691 | Common Stock |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,833 | 8,500 | - | - | Restricted Stock Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,833 | 35,267 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,223 | 60,377 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,223 | 4,448 | - | - | Deferred Stock Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.83 per share. | 17 Feb 2022 | 832 | 34,435 (0%) | 0% | 42.8 | 35,635 | Common Stock |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,769 | 2,769 | - | - | Deferred Stock Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,769 | 33,247 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.01 per share. | 15 Feb 2022 | 813 | 32,434 (0%) | 0% | 44.0 | 35,780 | Common Stock |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 9,824 | 33,546 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 9,824 | 0 | - | - | Performance Share Units | |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.48 per share. | 01 Jan 2022 | 3,068 | 30,478 (0%) | 0% | 42.5 | 130,329 | Common Stock |
| Boston Scientific | Edward F. Mackey | EVP, Operations | Sale of securities on an exchange or to another person at price $ 42.71 per share. | 01 Jun 2021 | 68,173 | 23,722 (0%) | 0% | 42.7 | 2,911,580 | Common Stock |